SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-21-006313
Filing Date
2021-03-18
Accepted
2021-03-18 14:05:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13-da.htm SC 13D/A 76861
  Complete submission text file 0001493152-21-006313.txt   78481
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Subject) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51647 | Film No.: 21753892
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6888 SOUTH IRVINGTON COURT AURORA CO 80016
Business Address
Jemapete Christopher J (Filed by) CIK: 0001741021 (see all company filings)

Type: SC 13D/A